CAF-DCF is a BENELUX company focused on the commercialization of plasma-derived medicines, with a 40-year history in the field. Specializing in life-saving products for rare and life-threatening diseases in immunology, intensive care, and hemostasis, it operates with a commitment to ethical values, dedication to BENELUX healthcare services, and ensuring the safety of its products and patients. The company's "human-to-human approach" entails using blood plasma from dedicated volunteer donors to prepare products for patient treatment. CAF-DCF is under the control of the French biopharmaceutical group LFB, with historical roots tied to the Belgian Red Cross.
CAF-DCF
Life saving products in rare and often severe diseases
Founded 1975
Belgium
38 employees
Health Care, Pharmaceutical
Belgium
38 employees
Health Care, Pharmaceutical
General Information
Get notified when CAF-DCF moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CAF-DCF
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Belgium Market
Health Care
About CAF-DCF
Taxonomy: Plasma Derivatives, Rare Diseases, Life-saving Products, Immunology, Hemostasis, Intensive Care, Ethical Commitment, BioPharmaceuticals, Medicinal Products, Therapeutic Domains, Patient Safety, Medical Innovation
No funding data available for CAF-DCF yet.
Get notified when CAF-DCF raises fundingCAF-DCF Alternatives & Competitors
CAF-DCF vs
Octapharma Plasma, Inc.
United States
Turn plasma into hope.
2933 employees
Biotechnology, Health Care
CAF-DCF vs
Prothya Biosolutions
Belgium
Prothya Biosolutions aims to be a center of excellence in protein therapies for leading pharmaceutic...
Private Equity
712 employees
Biopharma, Biotechnology
CAF-DCF vs
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to prod...
Private Equity
2040 employees
Health Care
FAQ About CAF-DCF
Life saving products in rare and often severe diseases
CAF-DCF was founded in 1975.
CAF-DCF is headquartered in Belgium.
CAF-DCF operates in the following industries: Health Care, Pharmaceutical.
CAF-DCF has approximately 38 employees.
Top alternatives and competitors to CAF-DCF include Octapharma Plasma, Inc., Prothya Biosolutions, Kedrion Biopharma, ADMA Biologics, Inc., Talecris Biotherapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CAF-DCF and Octapharma Plasma, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors CAF-DCF and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.